Home page

Qualità e ricerca: è riconfermata la certificazione ISO 9001 per il processo di validazione delle pubblicazioni in IRIS-BOA

La norma ISO 9001 definisce i requisiti che il Sistema di Gestione per la Qualità di un'organizzazione deve dimostrare di soddisfare per garantire un livello adeguato di qualità del proprio prodotto/servizio: il 19 novembre 2025, dopo un costante lavoro di monitoraggio sul processo, SIR ha superato l'audit di sorveglianza annuale per il mantenimento della certificazione di qualità.
Il certificato ufficiale ISO è disponibile a questo link.

Prodotti recenti

Chronic kidney disease trajectories in lupus nephritis: Is progression unavoidable?

Objective: To characterize trajectories of chronic kidney disease (CKD) in lupus nephritis (LN) and identify predictors of CKD progression. Methods: At diagnosis, patients were classified as having impaired kidney function (IKF; eGFR <60 mL/min/1.73 m2,at diagnosis). At last follow-up, outcomes were defined as CKD (KDIGO stages 3–5), sustained complete renal response (CRR; eGFR >90 mL/min/1.73 m2, proteinuria <150 mg/day, inactive urinary sediment for ≥3 years). Predictors of CKD wer...

Analysing the Relationship Between Traffic Flows, Road Infrastructure, and Car Crashes Data: An Approach Based on Spatiotemporal Point Patterns on Linear Networks

Road accidents represent a concern for modern societies, especially in poor and developing countries. In this paper, we develop a road safety model assuming that the car crashes recorded in Milan (Italy) during 2019 can be appropriately modelled as a realisation of a spatio-temporal point process on a linear network. We adopt a separable first-order intensity function with spatial and temporal components. The temporal dimension is estimated semi-parametrically using an additive Poisson regres...

Tecfidera® (delayed-release dimethylfumarate) in the treatment of relapsing-remitting multiple sclerosis

The present health technology assessment (HTA) evaluates the clinical and economic profile of delayed-release dimethylfumarate (DMF, also known as gastro-resistant DMF) in the treatment of relapsing-remitting multiple sclerosis (RRMS) in Italy. Chapter 1 briefly introduces the condition (multiple sclerosis and, more specifically, the relapsing-remitting form) and provides an overall description of the main therapeutic options for physicians, in terms of clinical evidence, regulatory status in...

Bicocca Open Archive

Qualità e ricerca: è riconfermata la certificazione ISO 9001 per il processo di validazione delle pubblicazioni in IRIS-BOA

Prodotti recenti

Chronic kidney disease trajectories in lupus nephritis: Is progression unavoidable?

Analysing the Relationship Between Traffic Flows, Road Infrastructure, and Car Crashes Data: An Approach Based on Spatiotemporal Point Patterns on Linear Networks

Tecfidera® (delayed-release dimethylfumarate) in the treatment of relapsing-remitting multiple sclerosis

Use of Kovaltry® in patients with Hemophilia A: clinical and economical aspects from the pivotal clinical trials

CLINICAL CHARACTERISTICS AFFECTING DIRECT COSTS IN MULTIPLE SCLEROSIS

Link utili

Scopri

Dipartimento

Tipologia

Data di pubblicazione

140.571

pubblicazioni

31.553

open access

11.698.960

download

52.732

full text

10.453

autori